Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Fig. 1

Forest plot of hazard ratios and risk ratios comparing (a) progression-free survival, (b) overall survival, and (c) objective response rate in patients who received IO-Chemotherapy vs Chemotherapy alone. Squares represent study-specific effect size (HR or RR). The area of square is inversely proportional to the standard error of the study (and therefore indirectly to the sample size) and larger area indicates greater weight in the calculation of the pooled effect size. The horizontal line crossing the square represents the 95% CI. The diamonds represent the estimated overall effect, based on the meta-analysis. HR, hazard ratio; RR, relative risk; CI, confidence interval

Back to article page